Arena Pharma (ARNA) Reports Q3 Loss of $1.69/sh
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Financial Fact:
Research and development: 17.47M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Research and development: 17.47M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Arena Pharma (NASDAQ: ARNA) reported Q3 EPS of ($1.69), versus ($1.46) reported last year. Revenue for the quarter came in at $20 thousand, versus $1.35 million reported last year.
For earnings history and earnings-related data on Arena Pharma (ARNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CrowdStrike shares jump on earnings beat, raised outlook
- Okta, Inc. (OKTA) Tops Q2 EPS by 8c; offers guidance
- Agilent Technologies (A) Tops Q3 EPS by 13c, Beats on Revenue; Offers FY EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
